Market capitalization | $831.63m |
Enterprise Value | $831.63m |
P/E (TTM) P/E ratio | 4.57 |
EV/Sales (TTM) EV/Sales | 77.22 |
P/S ratio (TTM) P/S ratio | 77.22 |
P/B ratio (TTM) P/B ratio | 0.77 |
Dividend yield | 11.08% |
Last dividend (FY25) | $1.73 |
Revenue growth (TTM) Revenue growth | 4.66% |
As a Free StocksGuide user, you can view scores for all 6,847 stocks worldwide.
Sep '24 |
+/-
%
|
||
Revenue | 11 11 |
5%
5%
|
|
Gross Profit | 0.20 0.20 |
180%
180%
|
|
EBITDA | - - |
-
|
EBIT (Operating Income) EBIT | -0.35 -0.35 |
70%
70%
|
Net Profit | 185 185 |
229%
229%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Tekla Healthcare Investors is a closed-end investment fund, which engages in investing in the healthcare industry including biotechnology, medical devices, and pharmaceuticals. Its objective is to provide long-term capital appreciation through investments in companies in the healthcare industry. The company was founded on October 31, 1986 and is headquartered in Boston, MA.
Head office | United States |
Founded | 1986 |
Website | www.abrdnhqh.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.